Patents by Inventor Peter Bove

Peter Bove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the Treatment of Cystic Fibrosis
    Publication number: 20170281612
    Abstract: The present invention is directed to a method of treating or lessening the severity of cystic fibrosis in a patient, comprising the step of administering to said patient an effective amount of an inhibitor of S-nitrosoglutathione reductase (GSNOR) in combination with one or more secondary active agents.
    Type: Application
    Filed: October 8, 2015
    Publication date: October 5, 2017
    Inventors: Sherif Gabriel, Peter Bove
  • Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis
    Publication number: 20070275481
    Abstract: The invention provides a method of using chip-based gel electrophoresis to determine the presence of polypeptides with selected disulfide linkage patterns, for example, completely formed tetrameric antibodies as compared to incompletely formed heterodimeric half-antibodies. The invention further features a kit, comprising a chip, and instructions for conducting the foregoing method. The methods and kits of the invention are amendable to high throughput applications for the monitoring of production and quality control of recombinant therapeutic antibodies.
    Type: Application
    Filed: November 23, 2004
    Publication date: November 29, 2007
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Elena Vasilyeva, Francine Brown, Matthias Kretschmer, Peter Bove, Hans Fajardo, Frederick Taylor, Rohin Mhatre, Kazumi Kobayashi, Amy Dingley
  • Methods for detecting half-antibodies using chip-based gel electrophoresis
    Publication number: 20050176157
    Abstract: The invention provides a method of using chip-based gel electrophoresis to determine the presence of polypeptides with selected disulfide linkage patterns, for example, completely formed tetrameric antibodies as compared to incompletely formed heterodimeric half-antibodies. The invention further features a kit, comprising a chip, and instructions for conducting the foregoing method. The methods and kits of the invention are amendable to high throughput applications for the monitoring of production and quality control of recombinant therapeutic antibodies.
    Type: Application
    Filed: December 19, 2002
    Publication date: August 11, 2005
    Inventors: Elena Vasilyeva, Matthias Kretschmer, Peter Bove, Francine Brown